Nobel Hygiene Limited, the maker of Friends adult diapers and Teddyy baby diapers, has filed its Draft Red Herring Prospectus with India's Securities and Exchange Board for an initial public offering, becoming the latest consumer-goods company to test the country's still-buoyant IPO pipeline. The Mumbai-based company describes itself as India's largest home-grown branded manufacturer of absorbent hygiene products by value among pure-play branded players in fiscal 2026, spanning the adult, baby and feminine hygiene categories.
The proposed offering comprises a fresh issue of equity shares worth up to Rs 150 crore, alongside an offer for sale of up to 1.55 crore equity shares (roughly 15.5 million shares) by existing shareholders. The company may also consider a pre-IPO placement of up to Rs 30 crore, not exceeding 20 percent of the fresh issue size, which would proportionately reduce the primary component of the offering if executed. Proceeds from the fresh issue are earmarked for debt repayment, expansion of production capacity at the company's Halol manufacturing facility in Gujarat, and general corporate purposes, according to the filing.
The offer-for-sale portion is being led by healthcare-focused private equity firm Quadria Capital, through its investment vehicle Orbit Investment Holdings, which plans to offload roughly 9.57 million shares. Sixth Sense Ventures is next in line with 5 million shares on offer, followed by Bennett Trading LLP and a handful of individual shareholders, including Manish Dharanendra Ladage, Seema Manish Ladage and Lashit Lallubhai Sanghvi. Promoters Kamal Kumar Johari and Kamini Kamal Johari, who built the company from its origins as a home-grown challenger to multinational hygiene brands, are also participating in the secondary sale.
The filing follows an internal restructuring first reported in June 2026, when Nobel Hygiene converted into a public company in preparation for its market debut — a routine but telling procedural step that signalled the IPO process was already well underway before the formal DRHP filing in August. Because the company did not meet SEBI's minimum profitability and net-worth thresholds under Regulation 6(1)(b) of the ICDR framework through the standard route, it is understood to be pursuing the offering via the regulator's alternative eligibility criteria, a path increasingly used by fast-growing consumer companies that have prioritised market-share expansion over near-term profitability.
Nobel Hygiene's listing attempt adds to what has been a steady, if unspectacular, run of Indian IPO filings through August 2026, in a market that has swung between enthusiasm for consumer and manufacturing names and caution around richly valued technology listings. For Quadria Capital, a partial exit via IPO would mark a successful conclusion to one of its earlier consumer-health bets, at a time when the healthcare-focused investor is simultaneously raising fresh capital for its next fund. Whether public-market investors reward Nobel Hygiene's category leadership with a premium multiple, or discount it against slower-growing multinational incumbents, will become clearer once the company sets a price band and opens its issue for subscription.
